Delivery Order SPE2DB20D3101-SPE2DB23FRSV0
Award Date 7/27/23
Potential Completion Date 7/28/23
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,320.15 contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a performance period through June 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,836.52, is for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to manage diabetes. The contract has a firm fixed price of $42,053.35 and a completion date of March 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a $5,932.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,801.11 Firm Fixed Price Delivery Order is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90 tablets of the diabetes medication Jardiance 10 mg. The contract has a ceiling value of $3,856.75 and a completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,449.56 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 24, 2023 and was awarded on April 23, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is valued at $5,727.04 and is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has a period of performance through May 30, 2024 and is priced as a firm fixed-price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,337.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a $28,170.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 90-count tablets of Jardiance 10 mg, a medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRSV0Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,453.21, is for the delivery of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The delivery order has a completion date of July 28, 2023 and was awarded on July 27, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 11:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/27/23 |